Latest / Stuff You Should Know / SYSK Gets Weird Playlist: What is Collective Hysteria?
Transcript
- 0:03Speaker 1: Hey everybody and welcome to the Stuff You Should Know
- 0:06Speaker 1: Gets Weird playlist. This is another one of our quarterly playlists, everyone,
- 0:10Speaker 1: that we compile because we found that people like us
- 0:13Speaker 1: sort of grouping things and bucketing things and cataloging things
- 0:16Speaker 1: into groups of 10 to 12. And I think we
- 0:18Speaker 1: have 11 of them this time out. And we're getting
- 0:20Speaker 1: started this week with the inaugural episode of the Stuff
- 0:23Speaker 1: You Should Know Gets Weird playlist with our episode, What
- 0:26Speaker 1: is Collective Hysteria? So please give a listen and enjoy it.
- 0:35Speaker 2: Welcome to Stuff You Should Know from HowStuffWorks.com.
- 0:45Speaker 3: Hey, and welcome to the podcast. I'm Josh Clark. With me,
- 0:48Speaker 3: as always, is Charles W. Chuck Bryant. And Jerry's over
- 0:51Speaker 3: there to the left. And that makes this Stuff You
- 0:54Speaker 3: Should Know.
- 0:55Speaker 4: Got the A-team in the hizzy.
- 0:58Speaker 3: I call face.
- 1:00Speaker 1: What?
- 1:01Speaker 3: I'm face.
- 1:02Speaker 4: Oh, of course you're face. Look at you. I would
- 1:05Speaker 4: be a combination of Murdoch and Mr. T, I think. Yeah.
- 1:09Speaker 3: Well, your hair is kind of spiky in the middle today.
- 1:11Speaker 4: Yeah. Jerry, I don't know what she'd be. I guess
- 1:15Speaker 4: she'd be the leader. She'd be Hannibal.
- 1:17Speaker 3: Oh, yeah.
- 1:18Speaker 4: You know?
- 1:18Speaker 3: She's smoking a cigar right now.
- 1:20Speaker 4: And wearing a black glove.
- 1:21Speaker 3: When did you start smoking cigars, Jerry?
- 1:23Speaker 4: That's weird.
- 1:24Speaker 3: Very timely.
- 1:26Speaker 4: I said A-team. I don't want to slag off guest
- 1:29Speaker 4: producer Noel. He's not exactly B-team. No. We'll just call
- 1:32Speaker 4: ourselves the OGs.
- 1:34Speaker 3: Okay. Now that we have that established, we are the OGs.
- 1:38Speaker 4: That's right.
- 1:38Speaker 3: We need bowling shirts that say as much on the back.
- 1:42Speaker 3: You feeling good?
- 1:43Speaker 4: I'm feeling nauseous and dizzy.
- 1:47Speaker 3: Oh, well, Chuck, did you happen to see somebody else
- 1:50Speaker 3: who is nauseous and dizzy?
- 1:51Speaker 4: Well, Jerry was last week, and then a few more
- 1:54Speaker 4: people in the office, so I just figured we all
- 1:55Speaker 4: had the same thing.
- 1:56Speaker 3: All right. I'm going to diagnose this.
- 1:58Speaker 4: Okay.
- 1:59Speaker 3: It's called collective hysteria, also known, I think... more appropriately,
- 2:05Speaker 3: is mass psychogenic disorder.
- 2:07Speaker 4: Yeah.
- 2:07Speaker 3: I think when you add the word hysteria to this,
- 2:10Speaker 3: it takes on certain dimensions that a lot of people
- 2:13Speaker 3: could find very objectionable.
- 2:15Speaker 4: Sure.
- 2:15Speaker 3: You know, hysterics, hysteria, it's like.
- 2:19Speaker 4: Dogs and cats living together.
- 2:21Speaker 3: Yeah, but I think it has a definite gender-specific connotation
- 2:28Speaker 3: to it from over the years. Like, women were supposedly
- 2:31Speaker 3: very hysterical. So, the idea of diagnosing somebody as hysterical
- 2:37Speaker 3: under any circumstances is kind of a tad amount to
- 2:40Speaker 3: patting them on the head.
- 2:42Speaker 4: Yeah, here, nice lady, you're just a little hysterical. You
- 2:45Speaker 4: just go calm down and bake something. Right.
- 2:47Speaker 3: Stop being crazy. No, mass psychogenic disorder instead is just
- 2:51Speaker 3: kind of like, whoa, your brain just did something pretty neat.
- 2:55Speaker 4: Yeah.
- 2:55Speaker 3: And that is the case for mass psychogenic disorder, if
- 2:58Speaker 3: you ask me. In this article, Chuck, written by Jacob Silverman.
- 3:04Speaker 4: Jeopardy champion.
- 3:05Speaker 3: Yeah, well, yeah. Yeah, he won on Jeopardy. That makes
- 3:08Speaker 3: him a champion, right?
- 3:08Speaker 4: Yeah, I think so. He wasn't, like, the ultimate champion,
- 3:11Speaker 4: but he won a couple of episodes.
- 3:13Speaker 3: Right, which is why they should have a word for,
- 3:15Speaker 3: I guess, like, champion is, like, the one who won
- 3:19Speaker 3: it all.
- 3:19Speaker 4: Ken Jennings.
- 3:21Speaker 3: Yeah, or Watson.
- 3:23Speaker 4: Who's that?
- 3:24Speaker 3: The IBM computer.
- 3:25Speaker 4: Oh, well, yeah, sure.
- 3:27Speaker 3: So Jeopardy winner Jacob Silverman wrote this article years back,
- 3:31Speaker 3: and he did a pretty great job of citing... a, uh,
- 3:34Speaker 3: contemporary outbreak of mass psychogenic disorder that had been going
- 3:40Speaker 3: on around that time down in Mexico, down Mexico way
- 3:43Speaker 3: in Chalco, Mexico at a boarding school there. Uh, it
- 3:48Speaker 3: apparently was a girl's boarding school and the girls that
- 3:51Speaker 3: went to school, they were ages 12 to 17 and
- 3:54Speaker 3: all of a sudden they started, uh, well, there was
- 3:57Speaker 3: an outbreak, a weird outbreak. There was vomiting, I believe,
- 4:01Speaker 3: trouble walking, um, There was fever. Yeah. That's weird.
- 4:07Speaker 4: Nausea.
- 4:08Speaker 3: And so the people running this boarding school were like,
- 4:12Speaker 3: what's going on? This is not good.
- 4:14Speaker 4: Yeah.
- 4:15Speaker 3: And they had no idea. The girls went on Christmas
- 4:18Speaker 3: break for 10 days, came back, and the thing just
- 4:22Speaker 3: took off again like wildfire.
- 4:23Speaker 4: Yeah. 600 of the 3,600 girls showed these symptoms and
- 4:27Speaker 4: nobody could figure it out. They did a lot of tests.
- 4:30Speaker 4: They brought in people to like check out the facilities. Yeah.
- 4:33Speaker 4: Because as you'll see, there's a trend there. You know,
- 4:38Speaker 4: here in the West, they start to blame it usually
- 4:40Speaker 4: on like environmental poisoning of some kind.
- 4:44Speaker 3: Right. You know, there's some sort of toxin present that
- 4:48Speaker 3: has poisoned everybody.
- 4:49Speaker 4: But they didn't find anything there. And eventually they said
- 4:54Speaker 4: this is. what'd you call it? Psychosomatic?
- 4:57Speaker 3: Mass psychogenic disorder.
- 4:59Speaker 4: Okay. Mass psychogenic disorder.
- 5:00Speaker 3: But no, that is one of the names. Mass psychogenic disorder,
- 5:04Speaker 3: collective hysteria, mass hysteria, or mass psychosomatic reaction.
- 5:09Speaker 4: Yeah. They're all saying the same thing.
- 5:11Speaker 3: They are.
- 5:11Speaker 4: Which is you're not, well, I was about to say
- 5:14Speaker 4: you're not really sick, but that is not exactly true
- 5:16Speaker 4: because that's one thing that differentiates this from something that's
- 5:19Speaker 4: just in your head is you actually do manifest physical symptoms.
- 5:22Speaker 3: Right.
- 5:23Speaker 4: Yeah.
- 5:23Speaker 3: There's this article written by a MD named Timothy F.
- 5:26Speaker 3: Jones from the Tennessee Department of Health way back in
- 5:30Speaker 3: the heady days of 2000, the year 2000, the future.
- 5:33Speaker 4: Wow.
- 5:34Speaker 3: And he writes that if you are experiencing mass psychogenic disorder,
- 5:41Speaker 3: it is not just in your head. that the symptoms
- 5:43Speaker 3: that you have are actually very real. Even though there's
- 5:46Speaker 3: no toxic cause, they couldn't find some sort of environmental
- 5:51Speaker 3: poisoning or anything like that, the symptoms are extremely real.
- 5:54Speaker 4: Yeah.
- 5:54Speaker 3: It's just psychosomatic. It's just basically the brain has been
- 5:58Speaker 3: tricked into causing this response.
- 6:02Speaker 4: Yeah, and this has happened. They've documented about 80 cases
- 6:06Speaker 4: throughout history, and apparently the National Institutes of Health gets
- 6:10Speaker 4: about two cases per week reported.
- 6:12Speaker 3: But, um, which is, I mean, like that's, that's way
- 6:15Speaker 3: more common than, than you would think.
- 6:18Speaker 4: You know? Yeah. I would think there'd be more than 80.
- 6:20Speaker 4: Cause I mean, these have happened. If you go back
- 6:22Speaker 4: and look at, I mean, there's all sorts of crazy
- 6:25Speaker 4: lists on the internet about these cases that date back
- 6:27Speaker 4: to like the 14th century.
- 6:29Speaker 3: Medieval dancing mania was one of them.
- 6:31Speaker 4: Yeah. The dancing plague. Yeah. Yeah. That's in there.
- 6:35Speaker 3: Uh, the Salem witchcraft trials.
- 6:37Speaker 4: Sure.
- 6:37Speaker 3: Or the Salem witchcraft, I guess what led to the
- 6:40Speaker 3: trials was, um, supposedly attributed to this kind of thing.
- 6:45Speaker 4: Yeah. One weird thing about this condition is more times
- 6:52Speaker 4: than not, it affects females.
- 6:55Speaker 3: Yeah.
- 6:55Speaker 4: And young females, even more specifically, teenagers or even younger.
- 6:59Speaker 3: Which is, as far as it goes right now, inexplicable.
- 7:04Speaker 3: And it's kind of a prickly issue, you know? Like, again,
- 7:07Speaker 3: you kind of come back to the idea of calling
- 7:09Speaker 3: it hysteria. Yeah. The fact that it does tend to
- 7:13Speaker 3: afflict women or girls more than boys is apparently one
- 7:20Speaker 3: means of diagnosing psychogenic disorder, mass psychogenic disorder.
- 7:23Speaker 4: Yeah, that's like one of the first things they'll say
- 7:25Speaker 4: is like all this sickness is happening in this place,
- 7:28Speaker 4: this school, wherever. And the doctor will say, is it
- 7:31Speaker 4: a bunch of girls? Yeah. And then that will clue
- 7:33Speaker 4: them in that, hey, this might be what we're dealing
- 7:35Speaker 4: with here.
- 7:37Speaker 3: But the problem is no one has any idea why.
- 7:39Speaker 3: And there have been explanations of things like, I guess,
- 7:46Speaker 3: this is girls' culturally acceptable outlet for raging against the patriarchy.
- 7:53Speaker 4: Sure.
- 7:54Speaker 3: Even if they don't necessarily feel that that's what they're doing,
- 7:57Speaker 3: this is the symptoms of that. That's one.
- 8:02Speaker 4: Yeah. I thought this was a pretty interesting part. What article?
- 8:05Speaker 4: Is that from Slate?
- 8:06Speaker 3: There was one called Mass hysteria in upstate New York
- 8:11Speaker 3: by Ruth Graham was on slate. That was a good one.
- 8:13Speaker 4: It was a really good one. We'll get to that
- 8:14Speaker 4: case in a sec. But I thought it was pretty interesting.
- 8:17Speaker 4: In one part it says, and this is a quote
- 8:20Speaker 4: from someone writing about something, it said, inform, if not
- 8:23Speaker 4: in conscious intent, it is to protest the sexual repressiveness,
- 8:27Speaker 4: rigid double standard of female teen culture. But they were
- 8:31Speaker 4: writing about Beatlemania.
- 8:32Speaker 1: Yeah.
- 8:33Speaker 4: Which is interesting because it sort of has a similar
- 8:35Speaker 4: vibe Of young ladies being repressed, not having an outlet.
- 8:42Speaker 4: And so they see the Beatles and they go berserk
- 8:45Speaker 4: and faint and cry and scream collectively. Whereas boys, they're
- 8:50Speaker 4: more prone to just act out if they're not feeling good.
- 8:52Speaker 4: Girls are trained to keep things inward. And they also
- 8:55Speaker 4: point out that ladies and young ladies are more prone
- 8:59Speaker 4: to seek a doctor's help for something. They say that
- 9:02Speaker 4: may account for the bias right there.
- 9:04Speaker 3: Right.
- 9:04Speaker 4: Like guys just won't go to the doctor.
- 9:06Speaker 3: Exactly. You have to be careful, though, in just diagnosing
- 9:09Speaker 3: mass psychogenic disorder. You physicians out there who are listening
- 9:13Speaker 3: that encounter a case like this, just by basing it
- 9:17Speaker 3: on the fact that it is affecting more girls than boys,
- 9:20Speaker 3: because there's at least one case in Great Britain where
- 9:24Speaker 3: I think girls were afflicted by more than half, more
- 9:28Speaker 3: than double the number of girls were afflicted by this.
- 9:31Speaker 3: And it turned out that there were tainted cucumbers being
- 9:33Speaker 3: served in the lunchroom.
- 9:35Speaker 4: Yeah. And everyone knows boys hate cucumbers.
- 9:38Speaker 3: So they didn't eat any. Right. But this is one
- 9:41Speaker 3: of the issues with dealing with mass psychogenic disorder in
- 9:45Speaker 3: that it looks and acts a lot like some sort
- 9:50Speaker 3: of weird epidemic. That basically it looks like either something
- 9:56Speaker 3: like bioterrorism. a rapidly spreading infection, or affection if it's
- 10:02Speaker 3: fetal mania, and then acute toxic exposure. That's what it
- 10:06Speaker 3: looks like. It's like one person gets sick. This is
- 10:09Speaker 3: your index case. And all of a sudden, everyone around
- 10:13Speaker 3: them suddenly has the same symptoms.
- 10:15Speaker 4: Yeah, and it's, like you said, it's super dangerous to
- 10:18Speaker 4: just dismiss that as, oh, it's all in your head,
- 10:21Speaker 4: silly little ladies. You can't do that because what if
- 10:24Speaker 4: it is something for real? But it's also a double-edged sword,
- 10:28Speaker 4: as that doctor pointed out. You start ordering batteries of tests,
- 10:33Speaker 4: and it can go both ways. It can, what the
- 10:37Speaker 4: old saying is, if you order enough tests, you're going
- 10:39Speaker 4: to find something.
- 10:40Speaker 3: Right.
- 10:40Speaker 4: So it can fuel that fire, but you also can't
- 10:43Speaker 4: not run any tests and just dismiss it. So it's
- 10:47Speaker 4: a very fine line that physicians walk when dealing with
- 10:50Speaker 4: stuff like this, for sure.
- 10:51Speaker 3: Indeed. Apparently, study of mass psychogenic disorder has found that
- 10:57Speaker 3: it's more prevalent in isolated communities.
- 11:00Speaker 4: Yeah.
- 11:01Speaker 3: And in situations where there are highly rigid, formalized, structured rules.
- 11:08Speaker 4: Like a Catholic school in Mexico.
- 11:10Speaker 3: Exactly.
- 11:11Speaker 4: Yeah.
- 11:11Speaker 3: Or, again, Salem, Massachusetts in the 17th century.
- 11:15Speaker 4: Yeah.
- 11:15Speaker 3: You know, and apparently between 1973 and 1993, half of
- 11:23Speaker 3: all the outbreaks of psychogenic illness took place in schools.
- 11:28Speaker 4: Oh, yeah.
- 11:29Speaker 3: So that's possibly in part due to kids being susceptible
- 11:37Speaker 3: to it more.
- 11:38Speaker 4: Right.
- 11:39Speaker 3: But also because of that rigid formalized structure.
- 11:43Speaker 4: Yeah, and there's also usually a top-down effect, like it'll
- 11:45Speaker 4: start with a teacher or an older student, and then
- 11:49Speaker 4: the younger students follow suit, which, if you're talking influence,
- 11:54Speaker 4: would make sense for sure.
- 11:56Speaker 3: There was one very famous case. Apparently, there's not very
- 11:59Speaker 3: many actual academic studies on this. Yeah. But there's one
- 12:03Speaker 3: that came out of the New England Journal of Medicine
- 12:07Speaker 3: that described a case in 1998 in Tennessee where a teacher...
- 12:13Speaker 3: noticed some weird gas odor, a gassy odor.
- 12:18Speaker 4: Yeah.
- 12:19Speaker 3: Like the chemical kind.
- 12:21Speaker 4: Yeah, not like the guy on the front row tooted.
- 12:23Speaker 3: Right, exactly.
- 12:24Speaker 1: Yeah.
- 12:25Speaker 3: And she apparently started suffering symptoms. And all of a sudden,
- 12:31Speaker 3: like 180 students and teachers had to go to the
- 12:35Speaker 3: emergency room. The school was shut down for two weeks.
- 12:38Speaker 3: They did all this environmental testing, couldn't find anything.
- 12:41Speaker 4: Yeah.
- 12:41Speaker 3: And finally- traced it back to a mass psychogenic disorder.
- 12:48Speaker 3: That's what did it.
- 12:49Speaker 4: And then everyone, in most of these cases, we should
- 12:52Speaker 4: point out, everyone starts feeling better.
- 12:55Speaker 3: Yes.
- 12:55Speaker 4: Like in Mexico and then the school in Tennessee, it's
- 12:59Speaker 4: not like they went on to die or anything.
- 13:00Speaker 3: Yeah, so in the school in Mexico, these girls were
- 13:05Speaker 3: at a boarding school.
- 13:06Speaker 4: Yeah.
- 13:07Speaker 3: They were only allowed to see their parents, I think,
- 13:08Speaker 3: like three times a year.
- 13:10Speaker 4: Yeah, they couldn't even call. It's like, it sounds more
- 13:12Speaker 4: like a prison. Right.
- 13:13Speaker 3: No phone calls. They were allowed letters. When they went home,
- 13:17Speaker 3: immediately their symptoms cleared up.
- 13:18Speaker 4: Yeah.
- 13:19Speaker 3: The problem is that doesn't automatically say, oh, well, it's
- 13:22Speaker 3: obviously mass psychogenic disorder. It could be an environmental toxin
- 13:26Speaker 3: that they were being exposed to still.
- 13:27Speaker 1: Right.
- 13:28Speaker 3: At the school and were removed from, but I think the...
- 13:33Speaker 3: Definite prognosis is mass psychogenic disorder in this case.
- 13:38Speaker 4: That's right. What we're talking about is a sort of
- 13:40Speaker 4: version of the nocebo effect, which we've talked about before,
- 13:43Speaker 4: and we will get into that right after this break.
- 13:50Speaker 4: So the nocebo effect, we talked about that in what?
- 13:55Speaker 3: The placebo effect.
- 13:56Speaker 4: Oh, well, that makes sense. Yeah. I was... Trying to
- 13:59Speaker 4: be more clever. Thought we were more clever than that. Nocebo,
- 14:03Speaker 4: I think we said in that other podcast too, is
- 14:05Speaker 4: Latin for I shall harm. And that's basically, whereas you
- 14:08Speaker 4: take a placebo thinking it's going to help you out,
- 14:10Speaker 4: and it does help you out because the mind is powerful.
- 14:14Speaker 4: The nocebo effect is thinking something bad will result. Like
- 14:18Speaker 4: my teacher's getting sick. I think I feel a little
- 14:20Speaker 4: sick too. And then, oh wait, my neighbor's feeling a
- 14:23Speaker 4: little sick. I think I'm feeling a little sick too.
- 14:25Speaker 3: Or this drug trial that I'm on. I was told
- 14:28Speaker 3: that I could, possibly get some sort of gastrointestinal distress. Yeah.
- 14:34Speaker 3: And even though I've been given a sugar pill, I'm
- 14:37Speaker 3: now going, yeah, because of my mind, because of the
- 14:41Speaker 3: nocebo effect.
- 14:43Speaker 4: There was a famous experiment or case from 1886 where
- 14:46Speaker 4: there was a woman who had a rose allergy and
- 14:50Speaker 4: they showed her an artificial rose and she began to,
- 14:53Speaker 4: I guess it was convincing, and she began to have
- 14:56Speaker 4: her allergic reaction And they said, aha, it's fake. And
- 15:01Speaker 4: you're faking. And she said, oh, well, I think I'm
- 15:05Speaker 4: feeling better now. And supposedly that cured her of her
- 15:09Speaker 4: real allergy to real roses.
- 15:12Speaker 3: Right.
- 15:13Speaker 4: I couldn't find a lot to back that up. But
- 15:15Speaker 4: it is a story.
- 15:16Speaker 3: Yeah, well, no. I mean, it was in, I can't
- 15:19Speaker 3: remember the journal.
- 15:20Speaker 4: Oh, it really was?
- 15:21Speaker 3: Yeah, it was a real deal thing. And I didn't
- 15:25Speaker 3: get to the bottom of why. They presented this woman
- 15:29Speaker 3: with a fake rose or whatever, but they definitely didn't.
- 15:32Speaker 3: This definitely happened. Yeah. And even the author of the
- 15:37Speaker 3: study was saying, like, this woman, she wasn't faking.
- 15:41Speaker 4: Right.
- 15:41Speaker 3: It was like she had real symptoms. Sure.
- 15:44Speaker 4: Hives are hives.
- 15:45Speaker 3: Exactly.
- 15:46Speaker 4: You can see those.
- 15:47Speaker 3: I think they call it like a rose cold or
- 15:49Speaker 3: something like that. You can get, you know, stuffy.
- 15:53Speaker 4: Yeah.
- 15:53Speaker 3: Your eyes are watering, your nose is running, that kind
- 15:56Speaker 3: of thing. And what's interesting is some researchers have studied
- 16:01Speaker 3: the nocebo effect, and they basically have isolated this chemical
- 16:07Speaker 3: that gets released when the nocebo effect's going on. And again,
- 16:12Speaker 3: we should say it's not just making your nose runny
- 16:15Speaker 3: or releasing histamines or anything like that. It's pain, too.
- 16:18Speaker 3: You can experience pain even though nothing's there to give
- 16:23Speaker 3: you pain just because of the nocebo effect. What they
- 16:26Speaker 3: found was a, I guess, a hormone, I believe. Are
- 16:33Speaker 3: you ready? I'm going to try this one. Cholecystokinin.
- 16:38Speaker 4: That sounds great.
- 16:39Speaker 3: Thanks, man.
- 16:39Speaker 4: I haven't looked at the word, but it sounds right.
- 16:41Speaker 3: Cholecystokinin.
- 16:42Speaker 4: Yeah.
- 16:45Speaker 3: Do you see it now?
- 16:45Speaker 1: Oh, yeah.
- 16:46Speaker 4: That's totally right.
- 16:47Speaker 3: I totally did. So it's a hormone, right? And it
- 16:48Speaker 3: gets released, and it actually helps you experience pain. So
- 16:55Speaker 3: it's a nasty little hormone.
- 16:56Speaker 4: Yeah.
- 16:57Speaker 3: But they found in testing with the nocebo effect that
- 17:00Speaker 3: if you block this, you can also block the nocebo effect.
- 17:04Speaker 3: So that proves two things.
- 17:05Speaker 4: Does that block pain though? Yes. Like your pain receptors? Yes.
- 17:08Speaker 4: So does that mean if you slam your hand in
- 17:09Speaker 4: a door, you won't feel it?
- 17:11Speaker 3: If you can block this.
- 17:12Speaker 4: Wow.
- 17:12Speaker 3: Yes. So if you can block cholecystokinin.
- 17:16Speaker 1: Right.
- 17:18Speaker 3: Yes. It will keep you from hypersensitivity to pain, I believe.
- 17:22Speaker 4: Yeah.
- 17:22Speaker 3: And this guy named Fabrizio Benedetti, who I think was
- 17:26Speaker 3: also in the strokes, back in 1997. There was a Fabrizio, right?
- 17:30Speaker 4: Yeah.
- 17:32Speaker 3: He was testing out the nocebo effect and found that
- 17:35Speaker 3: if he told people that he was giving them an injection,
- 17:37Speaker 3: which is a pretty cruel test, but effective. Yeah. These
- 17:42Speaker 3: post-op people who had just come out of surgery were
- 17:47Speaker 3: given an injection and told this injection is going to
- 17:50Speaker 3: increase your pain in 30 minutes. I'm sorry, we have
- 17:52Speaker 3: to give it to you. It's part of the procedure.
- 17:55Speaker 3: He gave some people an injection of saline and they
- 17:58Speaker 3: reported an increase in pain.
- 18:00Speaker 4: And they all went behind the two-way mirror and laughed. Right.
- 18:03Speaker 3: They're like, what a chump.
- 18:04Speaker 4: Look at him writhing.
- 18:07Speaker 3: And then they gave somebody like the other group, the
- 18:09Speaker 3: control group, a chemical, an injection that blocks that pain,
- 18:14Speaker 3: but they were told that it was going to increase
- 18:17Speaker 3: their pain.
- 18:18Speaker 4: Right.
- 18:18Speaker 3: But they were given a chemical that blocks cholecystokinin and
- 18:23Speaker 3: the nocebo effect didn't take place. They didn't report an
- 18:26Speaker 3: increase in pain.
- 18:26Speaker 4: Even though they were told they would. Yes. Wow.
- 18:29Speaker 3: So this guy's saying like the nocebo effect is real.
- 18:34Speaker 4: Yeah.
- 18:34Speaker 3: Like when they say it's not just in your head.
- 18:36Speaker 4: Sure.
- 18:37Speaker 3: You're experiencing the same thing as if you were experiencing
- 18:42Speaker 3: somebody stabbing you.
- 18:43Speaker 4: Well, what it is real, you know, that's when you
- 18:45Speaker 4: have to start asking yourself those deep philosophical questions. Right. Interesting. Um, there's, uh,
- 18:51Speaker 4: another case that's, have you ever seen the movie safe?
- 18:56Speaker 4: The Todd Haynes movie with Julianne Moore?
- 18:58Speaker 3: No.
- 18:59Speaker 4: It's from like, uh, the mid nineties. And she played
- 19:02Speaker 4: a lady that, um, started to have environmental sickness, um,
- 19:07Speaker 4: just in the air. And she's got sort of like increasingly, um,
- 19:12Speaker 4: crazy as the movie went on as far as scrubbing
- 19:14Speaker 4: things and locking herself in her house and making her
- 19:16Speaker 4: house a clean environment.
- 19:17Speaker 3: Sounds great.
- 19:19Speaker 4: It was good. And there's a true story, though, of
- 19:22Speaker 4: a lady in London named Debbie Bird. She's a health
- 19:25Speaker 4: spa manager that says that she's allergic to EMF, electromagnetic fields.
- 19:33Speaker 4: And it's an actual thing now. You know, there's more
- 19:36Speaker 4: than her claiming it's called ES, electromagnetic sensitivity, where she has...
- 19:42Speaker 4: basically transformed her house. She painted it black. She said
- 19:46Speaker 4: she's allergic to computers, cell phones, microwaves. She had her
- 19:50Speaker 4: house rewired to make it basically EMF free. She and
- 19:56Speaker 4: her husband sleep under a silver plated mosquito net to
- 19:59Speaker 4: keep out radio waves and covered all her windows with
- 20:02Speaker 4: protective films. And she said she's feeling a lot better now.
- 20:05Speaker 3: So I saw that ES, electromagnetic sensitivity, that if you
- 20:10Speaker 3: expose somebody to an electromagnetic field and then just tell
- 20:15Speaker 3: them that you are and don't, they have the same reaction,
- 20:19Speaker 3: which would suggest that it's nocebo.
- 20:22Speaker 4: Well, it's super fascinating because you see cases like this
- 20:26Speaker 4: from that to like gluten sensitivity becoming a big thing now.
- 20:30Speaker 4: And people, some people contend that, well, it's maybe a
- 20:33Speaker 4: collective hysteria going on.
- 20:35Speaker 1: Yeah.
- 20:35Speaker 4: If you think you're going to be sensitive to gluten,
- 20:37Speaker 4: then you're going to be sensitive to things that contain gluten.
- 20:40Speaker 4: And I'm not saying that, people, because that's a very
- 20:42Speaker 4: hot topic.
- 20:43Speaker 3: Sure it is.
- 20:43Speaker 4: But some people have claimed that.
- 20:47Speaker 3: Well, we'll talk a little bit more about things that
- 20:49Speaker 3: exacerbate the mass psychogenic disorder and the nocebo effect right
- 20:54Speaker 3: after this. Stuff you should know. Stuff you should know. So, Chuck,
- 21:05Speaker 3: back in 2007 in New Zealand, a drug called L-troxin.
- 21:12Speaker 3: It was a pretty widespread drug in New Zealand. It's
- 21:15Speaker 3: a hormone replacement drug. And it was the only one
- 21:17Speaker 3: that the government would pay for. So most people who
- 21:20Speaker 3: were on this hormone replacement therapy were using L-troxin. And
- 21:23Speaker 3: it had been that way for, like, decades.
- 21:26Speaker 4: Yeah.
- 21:26Speaker 3: It was just an established drug. GlaxoSmithKline.
- 21:29Speaker 4: What was it for, though?
- 21:30Speaker 3: Hormone replacement.
- 21:31Speaker 4: Oh, okay.
- 21:32Speaker 3: GlaxoSmithKline.com. I think just those, there's no welcome involved, changed
- 21:39Speaker 3: just the outer, the inner qualities of it, like the
- 21:43Speaker 3: shape of the pill, the color. And I think that's
- 21:46Speaker 3: about it. But the active ingredient was exactly the same
- 21:51Speaker 3: in 2007. And when they released it, all of a sudden,
- 21:56Speaker 3: some reports of bad side effects were starting to trickle in.
- 22:01Speaker 3: And the government was like, wait, what's going on here?
- 22:04Speaker 3: It got a little bit of media attention and more
- 22:08Speaker 3: reports started trickling in.
- 22:09Speaker 4: Yeah.
- 22:09Speaker 3: And then the media attention grew and the reports grew
- 22:12Speaker 3: and grew. And apparently the reporting of adverse effects of
- 22:17Speaker 3: L-troxin increased 2,000 fold in a year and a half.
- 22:23Speaker 4: Because of the look of the pill.
- 22:24Speaker 3: Because of the look of the pill.
- 22:25Speaker 4: Yeah.
- 22:26Speaker 3: They went back and studied this and they found that
- 22:28Speaker 3: in areas where there was more reporting about these adverse
- 22:32Speaker 3: effects being reported for L-troxin, the more adverse effects were
- 22:36Speaker 3: being reported in that area. And that kind of reveals
- 22:39Speaker 3: one of the risk factors for mass psychogenic disorder is
- 22:45Speaker 3: the media. It's actually spread through the media most easily.
- 22:49Speaker 4: Yeah, they have a point, though. I mean, I know
- 22:52Speaker 4: in this article, too, it points out that pills that
- 22:54Speaker 4: are blue and green are usually associated with drowsiness. Pills
- 22:58Speaker 4: that are orange or yellow are are not, and I
- 23:02Speaker 4: don't know if that's why they market it that way
- 23:04Speaker 4: or if it's the opposite, is we just see it
- 23:06Speaker 4: that way because of products like NyQuil and DayQuil. But
- 23:09Speaker 4: the one that makes you sleepy is green and blue,
- 23:12Speaker 4: and the one that keeps you awake, or not keep
- 23:14Speaker 4: you awake, but doesn't make you drowsy is orange.
- 23:16Speaker 3: I thought about it. I think, I mean, what do
- 23:18Speaker 3: you associate with, like, daytime, sunrise, yellow, orange, red?
- 23:22Speaker 4: It totally makes sense.
- 23:23Speaker 3: What do you associate with nighttime? Like, something tranquil, like blue.
- 23:27Speaker 4: Oh, yeah.
- 23:28Speaker 3: Yeah, scotch amber. Uh, yeah, you, I mean, you think of, uh,
- 23:32Speaker 3: that's what I, I, I think it came from, I
- 23:35Speaker 3: think the pills came after the association rather than the
- 23:38Speaker 3: other way around.
- 23:39Speaker 4: Yeah. I think I even, like when I get a
- 23:43Speaker 4: prescription for something, when I see the pill, I make
- 23:46Speaker 4: a judgment on it before I've even had it just
- 23:48Speaker 4: by saying, wow, look at that thing. It's heavy.
- 23:51Speaker 3: Yeah.
- 23:51Speaker 4: That's a horse pill or that's a capsule with, uh,
- 23:54Speaker 4: you know, powdery stuff inside that's different than the chalky one.
- 23:58Speaker 4: It's you. I think you just make an association. I
- 24:00Speaker 4: don't think I have any preconceived notions on what a
- 24:03Speaker 4: larger pill will do to me.
- 24:05Speaker 3: Right.
- 24:05Speaker 4: Or a capsule will do to me other than a tablet.
- 24:08Speaker 4: But I think it's interesting, though, how you make these
- 24:11Speaker 4: judgment calls.
- 24:13Speaker 3: But without even thinking about it.
- 24:14Speaker 4: Yeah, totally.
- 24:14Speaker 3: You know, I mean, like you probably don't sit there
- 24:18Speaker 3: and look at a pill in your hand. You just
- 24:20Speaker 3: take it and just make some sort of almost unconscious judgment.
- 24:25Speaker 3: judgments about it.
- 24:26Speaker 4: Yeah, it may remind you of another pill that helped
- 24:28Speaker 4: you that you're not even remembering.
- 24:29Speaker 3: Exactly. So that would be placebo.
- 24:31Speaker 4: Yeah.
- 24:31Speaker 3: That's great. Nocebo effect poses a lot of problems. For instance,
- 24:39Speaker 3: there was a study, I think, in the 90s that
- 24:42Speaker 3: found that women who believed that they were prone to
- 24:45Speaker 3: heart disease were four times likelier to die of heart
- 24:49Speaker 3: disease than than women who didn't believe they were prone
- 24:52Speaker 3: to it, even though they had all the exact same
- 24:55Speaker 3: risk factors, basically the same risk factors. There was nothing
- 24:58Speaker 3: differentiating these women aside from a belief that they were
- 25:01Speaker 3: going to die from heart disease or a belief that
- 25:04Speaker 3: they weren't. And that led to a four-fold increase in
- 25:09Speaker 3: deaths from that, just basically from a belief is what
- 25:13Speaker 3: it suggests.
- 25:14Speaker 4: Yeah, well, it's sort of like the, I know it's
- 25:17Speaker 4: kind of cheesy, but the PMA, the positive mental attitude,
- 25:20Speaker 4: I think we've all know someone who walks around saying, oh,
- 25:24Speaker 4: so-and-so's sick. Oh, I know I'm going to get it.
- 25:26Speaker 4: I just know I'm going to get sick. Or, you know,
- 25:28Speaker 4: I just know I'm going to get cancer because it
- 25:29Speaker 4: runs in my family. I think that has an effect
- 25:32Speaker 4: on things.
- 25:33Speaker 3: I have to agree. I know some of our more
- 25:35Speaker 3: skeptical listeners are pulling their hair out right now, but
- 25:38Speaker 3: I totally agree with you. When we did our show
- 25:41Speaker 3: in Toronto, on the way back, Yumi and I flew
- 25:44Speaker 3: out of Buffalo. And I was feeling a little down,
- 25:47Speaker 3: but like at the point where I feel like you
- 25:51Speaker 3: can talk yourself into staying healthy.
- 25:53Speaker 4: Yeah.
- 25:53Speaker 2: Yeah.
- 25:54Speaker 3: Positive mental attitude, I guess is what you call it.
- 25:56Speaker 3: But we were leaving right at about dusk and the
- 26:00Speaker 3: sun was just beaming through the windows and illuminating every
- 26:04Speaker 3: single microbe, visible microbe in the air. I could see
- 26:09Speaker 3: them like just going into my nose and my mouth.
- 26:12Speaker 3: And I'm like, I couldn't stop. Like I couldn't I
- 26:15Speaker 3: was like, I'm not going to get sick. I'm not
- 26:17Speaker 3: going to get sick. And man, did I ever get sick.
- 26:19Speaker 4: Yeah.
- 26:19Speaker 3: But I noticed that right when we took off and no,
- 26:24Speaker 3: you know what it was? Somebody shut one of their, um, their, uh,
- 26:27Speaker 3: window covers. Yeah. Yeah.
- 26:29Speaker 4: The shade.
- 26:30Speaker 3: Shade. Exactly. Is the word that I was looking for.
- 26:33Speaker 3: Somebody shut their shade and I couldn't see it anymore.
- 26:35Speaker 3: And I immediately started to feel less symptomatic.
- 26:39Speaker 4: Wow. Immediately.
- 26:40Speaker 3: It was like turning off a light.
- 26:41Speaker 4: Yeah.
- 26:41Speaker 3: And I still got sick. But I was just drowning
- 26:44Speaker 3: in basically what my brain was interpreting is like being
- 26:47Speaker 3: assaulted by foreign invaders, which I am all the time.
- 26:51Speaker 4: Sure.
- 26:51Speaker 3: But I normally can't see them.
- 26:52Speaker 4: Yeah. Well, I do that all the time when I
- 26:54Speaker 4: open my the curtains in the bedroom and I'll see
- 26:58Speaker 4: in the morning, I'll see that stuff in the air.
- 27:00Speaker 4: And I just think, oh, man, that's what I'm walking around.
- 27:02Speaker 3: Right.
- 27:02Speaker 4: Breathing in. Breathing.
- 27:03Speaker 3: Yeah.
- 27:04Speaker 4: Dog hair and cat hair and. Emily hair.
- 27:08Speaker 3: So your lungs are just chock full of it. So
- 27:12Speaker 3: one of the problems this poses, Chuck, for physicians is
- 27:16Speaker 3: that we expect doctors or we want doctors to be transparent,
- 27:22Speaker 3: to not lie to us.
- 27:23Speaker 4: Yeah, we've talked a lot about this lately, I feel like.
- 27:25Speaker 3: Yeah. We've talked a lot about diseases. Some of our
- 27:28Speaker 3: hypochondriac listeners have been like, please stop talking about diseases
- 27:33Speaker 3: because now I've got morgulons. I'm going to have like
- 27:37Speaker 3: some sort of toxic exposure.
- 27:39Speaker 4: Toxoplasmosis.
- 27:40Speaker 3: Yep. And then very soon, leprosy.
- 27:45Speaker 4: Spoiler.
- 27:46Speaker 3: So the problem is, is if you tell somebody that's
- 27:50Speaker 3: going into surgery, hey, by the way, Um, you know, you,
- 27:55Speaker 3: you might have trouble walking.
- 27:58Speaker 4: Yeah.
- 27:58Speaker 3: You might feel nauseous for the next six months. You
- 28:01Speaker 3: like all this stuff that could be associated with, which
- 28:04Speaker 3: we demand from our doctors.
- 28:05Speaker 4: Yeah.
- 28:06Speaker 3: It's been shown that if you are fearful or in
- 28:09Speaker 3: despair going into surgery, that's associated with longer healing times
- 28:14Speaker 3: and a higher risk of postoperative infection.
- 28:16Speaker 4: Yeah.
- 28:16Speaker 3: Right. So if you have the nocebo effect where doctors
- 28:20Speaker 3: are saying, Okay, if I tell somebody, and it's been
- 28:23Speaker 3: proven time after time that in drug trials, people who
- 28:27Speaker 3: are still are given placebo will drop out of drug
- 28:30Speaker 3: trials because they're experiencing these negative side effects, even though
- 28:36Speaker 3: they're given the sugar pill. So if you're a doctor
- 28:39Speaker 3: and you know that you are telling somebody something that
- 28:42Speaker 3: ultimately may end up harming them, and yet you've sworn
- 28:45Speaker 3: an oath to do no harm, you've got a conundrum
- 28:48Speaker 3: going on right now. And that's what the nocebo effect poses.
- 28:52Speaker 3: It's the problem the nocebo effect poses for modern physicians.
- 28:55Speaker 3: Like how much should they tell you? If you're going
- 28:57Speaker 3: to tell somebody that they're going to feel nauseous for
- 29:00Speaker 3: six months, even though they probably won't, should you tell
- 29:04Speaker 3: them and give them a chance to basically have the
- 29:08Speaker 3: psychosomatic symptom?
- 29:09Speaker 4: Or tell them they're going to feel great.
- 29:11Speaker 3: Well, that's another one. Somebody says the solution to this
- 29:14Speaker 3: is just frame it differently.
- 29:15Speaker 1: Right.
- 29:16Speaker 3: Like, don't say there's a chance you're going to have
- 29:19Speaker 3: nausea for six months. Say half of a percent of
- 29:24Speaker 3: patients who go through the same procedure that you're about
- 29:26Speaker 3: to go through have nausea for six months. 99.5% don't.
- 29:31Speaker 4: Right.
- 29:31Speaker 3: You're giving them the same information. It's just framed more positively.
- 29:35Speaker 4: Yeah. And that one doctor who wrote the article on
- 29:37Speaker 4: collectivist area said what he recommends is not naming the illness.
- 29:44Speaker 4: He said that can help out because as soon as
- 29:47Speaker 4: you give something a name, then... It just instantly, you know,
- 29:52Speaker 4: you have something you can call it and everyone's calling
- 29:53Speaker 4: it that or the media picks up on it. Right.
- 29:55Speaker 4: And it's a thing.
- 29:56Speaker 3: Yeah. And that's actually, again, one of the risk factors
- 30:00Speaker 3: in the spread of mass psychogenic illness is the larger
- 30:03Speaker 3: the response, the emergency medical response to it. Yeah. And
- 30:07Speaker 3: then hence the larger the media response to it, the
- 30:10Speaker 3: larger the outbreak tends to be. It's called line of
- 30:13Speaker 3: sight exposure. Yeah. Just knowing somebody is sick or seeing
- 30:17Speaker 3: somebody sick can give you the same symptoms.
- 30:20Speaker 4: I'm sure if you see a news story that all
- 30:22Speaker 4: the other news agencies are running that says there's been
- 30:25Speaker 4: some weird chemical leak in the air in Atlanta, people
- 30:29Speaker 4: are going to start walking around and coughing and saying,
- 30:33Speaker 4: I'm not feeling so good. I have a bitter taste
- 30:35Speaker 4: in my mouth.
- 30:36Speaker 3: There's microbes everywhere.
- 30:38Speaker 4: Well, here's a case from that article you sent that
- 30:41Speaker 4: I think is super fascinating. The one in upstate New York.
- 30:45Speaker 4: Because it is not a rash or a cough or nausea,
- 30:49Speaker 4: it is Tourette syndrome. A 16-year-old young lady named Lori Bronwell,
- 30:56Speaker 4: what year was this? A couple years ago?
- 30:58Speaker 3: Yeah, not too long ago. I think 2012.
- 31:00Speaker 4: In Corinth, New York, was... At her school's homecoming dance
- 31:05Speaker 4: and lost consciousness. This is after she had headbanged at
- 31:09Speaker 4: a concert.
- 31:10Speaker 3: Sorry, man. I thought you were going to leap out
- 31:11Speaker 3: like the best part.
- 31:12Speaker 4: Yeah, she was headbanging at a concert. I wish I
- 31:14Speaker 4: knew what concert that was so bad. Me too.
- 31:16Speaker 3: I didn't find it anywhere.
- 31:17Speaker 4: Apparently passed out there and had passing outfits. Involuntary twitching
- 31:21Speaker 4: and clapping started, twisting her hair, fluttering her fingers. Hey, hey, hey.
- 31:27Speaker 4: Starting stuff like that. Yeah. And the doctor said, you
- 31:30Speaker 4: know what? You've got Tourette's syndrome. So Tourette's syndrome is,
- 31:35Speaker 4: we've had a podcast on it.
- 31:36Speaker 3: It's a real thing.
- 31:36Speaker 4: It's not psychosomatic. But since that time, 14 other students
- 31:42Speaker 4: along with her, 13 girls and one boy started exhibiting
- 31:46Speaker 4: at Leroy Junior High School. I'm sorry, Junior Senior High
- 31:49Speaker 4: School started coming down with Tourette's.
- 31:51Speaker 3: Right, which is not contagious.
- 31:53Speaker 4: It is not contagious at all. Erin Brockovich got on
- 31:57Speaker 4: the case, famous environmental activist. And she said, no, I
- 32:01Speaker 4: think this is, got to do with this train derailment
- 32:04Speaker 4: from 1970 that dumped cyanide all over this town. And
- 32:09Speaker 4: I didn't see where they found any legitimate effects.
- 32:14Speaker 2: Right.
- 32:14Speaker 3: Again, that's the confounding thing about mass psychogenic disorder is
- 32:18Speaker 3: that it is still possible that there is some weird
- 32:22Speaker 3: toxin in the environment that is causing this. Like maybe
- 32:27Speaker 3: there was exposure to cyanide that got in these people's
- 32:29Speaker 3: brains and all gave them Tourette. And if you stand
- 32:33Speaker 3: back and look at it, you're like, Tourette syndrome isn't contagious.
- 32:38Speaker 3: That doesn't mean that you can't all come down with
- 32:41Speaker 3: Tourette syndrome from exposure to a toxin. It's just still,
- 32:44Speaker 3: it's this X factor that's out there that you can't
- 32:46Speaker 3: just necessarily rule out with confidence.
- 32:48Speaker 4: Yeah, and I believe in that case too, those 14
- 32:51Speaker 4: students didn't end up with Tourette syndrome.
- 32:54Speaker 3: That was a good episode, man. Loved Tourette syndrome one.
- 32:58Speaker 4: Yeah, that's an oldie.
- 32:59Speaker 3: Yeah.
- 32:59Speaker 4: Oldie but a goodie.
- 33:01Speaker 3: And it all came from headbanging.
- 33:04Speaker 4: That's how it started.
- 33:04Speaker 3: That mess.
- 33:05Speaker 4: At a Nickelback show.
- 33:08Speaker 3: Yeah, because Corinth is near Canada. Canada doesn't let Nickelback
- 33:13Speaker 3: out any longer.
- 33:13Speaker 4: Oh, really? Are they caged in there? Yeah. Nice. There's
- 33:17Speaker 4: another case of the toxic lady. Did you hear this one?
- 33:20Speaker 4: In Riverside, California, a woman named Gloria Ramirez.
- 33:24Speaker 3: Yeah.
- 33:24Speaker 4: She was dubbed the toxic lady in 1994. She had
- 33:27Speaker 4: cervical cancer and was being treated and all the medical
- 33:30Speaker 4: staff started to get sick that was treating her. This
- 33:34Speaker 4: sounds gross, but they said her body exuded a garlicky,
- 33:37Speaker 4: fruity smell, and her blood had flecks of what looked
- 33:40Speaker 4: like paper, which sounds kind of like Morgulans, actually.
- 33:44Speaker 1: Nice.
- 33:45Speaker 4: You like that?
- 33:45Speaker 3: Yeah.
- 33:47Speaker 4: And they said that most of the people that got
- 33:50Speaker 4: sick while treating her were women, more women than men,
- 33:54Speaker 4: and they all took a blood test and came back normal,
- 33:57Speaker 4: and the health department said, Mass hysteria.
- 33:59Speaker 3: So that's funny because I looked, I remembered that story
- 34:02Speaker 3: and I was like, I wonder if that was mass hysteria.
- 34:05Speaker 3: And I looked it up and I found that no,
- 34:06Speaker 3: it was an environmental toxin.
- 34:08Speaker 4: Oh, it was?
- 34:08Speaker 3: That's what I found.
- 34:09Speaker 4: So they called it mass hysteria at the time and
- 34:11Speaker 4: then later found out?
- 34:12Speaker 3: I think like a year or two later, she was
- 34:14Speaker 3: using some sort of salve or something on her skin.
- 34:18Speaker 3: And they think that it interacted with her biochemistry and
- 34:21Speaker 3: really did produce toxic gas.
- 34:24Speaker 4: She said it may be this fruit garlic salve.
- 34:26Speaker 3: Right, exactly.
- 34:27Speaker 2: Exactly.
- 34:27Speaker 3: That's interacting badly with my pancreas.
- 34:30Speaker 4: Oh, well, this list needs to be updated.
- 34:33Speaker 3: Dude, that is a fascinating case. It is. People got
- 34:37Speaker 3: really sick from that.
- 34:38Speaker 4: I think I remember hearing about that, too.
- 34:40Speaker 1: Yeah.
- 34:40Speaker 4: Well, I'm glad they found a real cause in that case.
- 34:42Speaker 3: From what I understand. But that's the point. Right. You
- 34:45Speaker 3: can say, well, obviously, women were more affected than men.
- 34:49Speaker 4: Yeah.
- 34:49Speaker 3: Right? Well, is that because there's more women in the
- 34:52Speaker 3: nursing profession and there were more nurses in the room?
- 34:55Speaker 4: Yeah, maybe.
- 34:55Speaker 1: Maybe.
- 34:55Speaker 3: There's a lot of different things you have to take
- 34:57Speaker 3: into account before you just write it off. Sometimes it
- 35:00Speaker 3: is real, like sick building syndrome.
- 35:02Speaker 1: Yeah.
- 35:03Speaker 3: That's a tough one because after the OPEC oil embargo,
- 35:09Speaker 3: apparently people started designing buildings to be more airtight. So
- 35:13Speaker 3: your ventilation system was really important.
- 35:16Speaker 1: Yeah.
- 35:17Speaker 3: And these buildings haven't aged necessarily very well. So the
- 35:20Speaker 3: ventilation system is not doing what it's supposed to any longer.
- 35:23Speaker 3: And so they think possibly that's leading to what we
- 35:26Speaker 3: know as sick building syndrome, which is malaise.
- 35:29Speaker 4: It's when you don't feel good when you go to work.
- 35:30Speaker 3: Exactly.
- 35:31Speaker 4: Which is everybody.
- 35:32Speaker 3: But some studies have found like, no, that is the
- 35:34Speaker 3: better predictor of sick building syndrome.
- 35:37Speaker 1: Yeah.
- 35:37Speaker 3: Is job stress or job dissatisfaction. Yeah. If you have
- 35:42Speaker 3: a building full of people who don't like their jobs,
- 35:44Speaker 3: you're going to have a building full of people with
- 35:46Speaker 3: sick building syndrome. But if you go on to say
- 35:48Speaker 3: like a local government's website or whatever, and you look at,
- 35:52Speaker 3: Sick building syndrome. It's treated as a real thing.
- 35:55Speaker 4: Yeah. Well, it definitely affects your gastrointestinal like stress does.
- 35:59Speaker 3: Also, apparently it can set off bouts of asthma.
- 36:02Speaker 4: Yeah.
- 36:03Speaker 3: Which is another reason why they think it might have
- 36:04Speaker 3: something to do with like volatile organic compounds in the
- 36:07Speaker 3: ventilation system. Or new carpeting, that kind of stuff.
- 36:10Speaker 4: Yeah. Off-gassing, man. You smell that stuff when you open
- 36:13Speaker 4: up a new product, right?
- 36:13Speaker 3: Yeah.
- 36:15Speaker 4: There's also the dancing plague, which we mentioned briefly.
- 36:18Speaker 3: Tell me about it.
- 36:20Speaker 4: Frowtrophia. July 14th, 1518, went out on the streets of Strasbourg, France,
- 36:26Speaker 4: and started dancing, even though there was no music, and
- 36:29Speaker 4: dancing like a maniac for three straight days. And all
- 36:32Speaker 4: these people started dancing with her, saying this is a
- 36:34Speaker 4: good time. It said within a month, 100 people were
- 36:38Speaker 4: dancing with her and couldn't stop. And hyperventilating, hallucinating, some
- 36:44Speaker 4: dropped dead of heart attack and stroke and exhaustion. And
- 36:48Speaker 4: the authorities said, let's just hire a band. And let
- 36:51Speaker 4: them dance it out.
- 36:52Speaker 3: Yeah.
- 36:52Speaker 4: Because they've got the hot blood is what they called it.
- 36:55Speaker 3: All right.
- 36:56Speaker 4: And so they did. And a lot of people died
- 37:00Speaker 4: as a result. It said 400 people in the end
- 37:02Speaker 4: were struck. I don't think they died, but were dancers.
- 37:07Speaker 3: Right.
- 37:07Speaker 4: And then it just stopped. And that's when they blame,
- 37:09Speaker 4: a lot of people blame on ergot poisoning, which we've
- 37:12Speaker 4: mentioned before.
- 37:13Speaker 3: I always go with ergot poisoning.
- 37:15Speaker 4: Yeah, back then.
- 37:15Speaker 3: Those people were clearly tripping on something.
- 37:17Speaker 4: They got the hot blood.
- 37:18Speaker 3: But what it sounds like you just described is basically
- 37:21Speaker 3: how Tom Hanks invented jogging in the 70s.
- 37:24Speaker 4: Yogging?
- 37:24Speaker 3: Yeah.
- 37:25Speaker 4: Oh, yeah?
- 37:26Speaker 3: He just started running and people started following him.
- 37:29Speaker 4: I wish that part had been cut out of that movie. Oh, really? Yeah,
- 37:32Speaker 4: I thought that it was a weird thing that should
- 37:35Speaker 4: have been on the editing room floor. It really kind
- 37:38Speaker 4: of derailed things for a while for me. Yeah. I
- 37:41Speaker 4: don't think that movie's aged well, though.
- 37:42Speaker 3: I haven't seen it in forever.
- 37:43Speaker 4: Other people say, though, that it was Sydenham's chorea. a
- 37:49Speaker 4: disorder linked to strep throat and rheumatic fever that causes
- 37:52Speaker 4: dance-like twitches. And then, of course, modern medical historians say
- 37:56Speaker 4: it was mass psychosis.
- 37:58Speaker 3: I would go with that one.
- 37:59Speaker 4: Yeah, but back then it made more sense, though, when
- 38:03Speaker 4: during the Salem witch trials and before they knew anything
- 38:06Speaker 4: about medicine and you could just say you got the
- 38:07Speaker 4: hot blood or you're having the fits.
- 38:10Speaker 3: Or the devil's possessed you.
- 38:13Speaker 4: Yeah, exactly. These modern cases are the ones that really
- 38:15Speaker 4: freak me out because so much is explainable now.
- 38:19Speaker 3: Here's the thing, though, Chuck. We've always explained it with
- 38:22Speaker 3: something that comes easily to mind. So back in the
- 38:25Speaker 3: day before science and medicine, it was the devil possessing you.
- 38:30Speaker 3: And don't think that people weren't freaked out when they
- 38:32Speaker 3: thought that the devil was there in town possessing people
- 38:35Speaker 3: in the same way that you're freaked out by the
- 38:38Speaker 3: idea that it's cyanide in the soil from a train
- 38:41Speaker 3: derailment from 1970.
- 38:41Speaker 4: Or beetle mania.
- 38:43Speaker 3: Exactly. Which is the deadliest of all the manias. But
- 38:47Speaker 3: it's just as real.
- 38:49Speaker 4: Yeah.
- 38:50Speaker 3: To the experiencer. And it all comes down to people
- 38:53Speaker 3: just basically being sick of the establishment and letting loose
- 38:56Speaker 3: for a while.
- 38:57Speaker 4: Don't want to go to work. Nice. So I'll dance.
- 39:01Speaker 3: You got anything else?
- 39:03Speaker 1: No, sir.
- 39:04Speaker 3: If you want to know more about collective hysteria, which
- 39:07Speaker 3: is the name of this article, type those words in
- 39:10Speaker 3: the search bar at howstuffworks.com and it will bring it up.
- 39:13Speaker 3: And I said search bar, which means it's time for
- 39:15Speaker 3: listener mail.
- 39:18Speaker 4: I'm going to call this episode on grief. We got
- 39:22Speaker 4: a lot of great feedback and they continue to roll in.
- 39:26Speaker 4: Hey guys, just stumbled upon your podcast through my tune
- 39:29Speaker 4: in radio app. Uh, I guess that's a mini plug.
- 39:32Speaker 4: We're available there now. Um, I've devoured almost all of
- 39:36Speaker 4: the 600 plus shows. I may be a new listener,
- 39:38Speaker 4: but I'm already a lifelong fan. So why I'm writing
- 39:41Speaker 4: in guys is I lost my twin sister back in 2010. Uh,
- 39:45Speaker 4: it was a rough time because as a fraternal twin,
- 39:47Speaker 4: me being the boy, uh, I looked at her not
- 39:49Speaker 4: only as a sister, but as a mother and friend, too.
- 39:52Speaker 4: Long story short, I wanted to comment on the Grief
- 39:54Speaker 4: show some time ago. I've dealt with my grief through
- 39:57Speaker 4: my artwork. I'm a small-town artist from Johnson City, Tennessee,
- 40:02Speaker 4: and I rarely can get noticed or any attention with
- 40:04Speaker 4: my art. I wanted to share my new piece I've
- 40:07Speaker 4: just finished after listening to how comic books work. I'm
- 40:10Speaker 4: a huge fan of Marvel Comics, and I hope you
- 40:11Speaker 4: both enjoy this. And he sent this really cool... I
- 40:14Speaker 4: think it was like every member of the Marvel Universe
- 40:16Speaker 4: had to be in this picture that he did.
- 40:19Speaker 3: I didn't see that one.
- 40:19Speaker 4: It's really, really neat. Just jam-packed full of Marvel comic
- 40:22Speaker 4: heroes and villains. So Josh and Chuck, thanks for the
- 40:26Speaker 4: inspiration laughs and getting through every day at the office. P.S.
- 40:29Speaker 4: My twin Jessica passed away from epilepsy, actually. A condition
- 40:33Speaker 4: called SUDEP, Sudden Unexplained Death of Epilepsy. My mother is
- 40:38Speaker 4: trying to raise awareness because November is Epilepsy Awareness Month.
- 40:42Speaker 4: So if you guys wouldn't mind mentioning this on the show,
- 40:44Speaker 4: she would be so happy for that. Also, an epilepsy
- 40:47Speaker 4: show would be cool, too. Not a lot is discussed
- 40:50Speaker 4: about it. And that is Jason Flack. And Jason, I
- 40:53Speaker 4: wrote you back. That is heartbreaking about your twin sister.
- 40:56Speaker 3: Yeah, it is.
- 40:57Speaker 4: Very sorry to hear that. And we will definitely do
- 41:00Speaker 4: a show on epilepsy. And since this is November, though,
- 41:04Speaker 4: people should go out and find out what they can
- 41:06Speaker 4: during National Epilepsy Month.
- 41:07Speaker 1: Yeah.
- 41:08Speaker 4: We'll follow up with the show. I don't know if
- 41:10Speaker 4: it'll be in November, but we'll get to that one
- 41:12Speaker 4: for sure.
- 41:12Speaker 1: Yeah.
- 41:13Speaker 4: And thanks for that piece of art. And if anyone's
- 41:15Speaker 4: interested in a great comic book artist from Johnson City, Tennessee,
- 41:18Speaker 4: I could do a lot worse than Jason Flack.
- 41:21Speaker 3: Jason, thank you very much for sharing that with everybody.
- 41:24Speaker 3: That means a lot to us. If you want to
- 41:27Speaker 3: share with us and all of our listeners out there,
- 41:31Speaker 3: you can tweet to us at SYSK Podcast. You can
- 41:34Speaker 3: join us on Facebook.com slash SubYouShouldKnow. You can send us
- 41:38Speaker 3: an email with attached artwork to StuffPodcast at HowStuffWorks.com. And
- 41:43Speaker 3: as always, join us at our home on the web, stuffyoushouldknow.com.
- 41:52Speaker 2: For more on this and thousands of other topics, visit howstuffworks.com.